4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholin e monohydrochloride

Suppliers

Names

[ CAS No. ]:
86871-73-0

[ Name ]:
4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholin e monohydrochloride

[Synonym ]:
Morpholine,4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)-,monohydrochloride
4-[2-[[5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride
4-(2-((5-(4-Chlorophenyl)-4-methyl-1H-pyrazol-3-yl)oxy)ethyl)morpholine monohydrochloride

Chemical & Physical Properties

[ Boiling Point ]:
502.3ºC at 760 mmHg

[ Molecular Formula ]:
C16H21Cl2N3O2

[ Molecular Weight ]:
358.26300

[ Flash Point ]:
257.6ºC

[ Exact Mass ]:
357.10100

[ PSA ]:
50.38000

[ LogP ]:
3.48940

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
QE0479590
CHEMICAL NAME :
Morpholine, 4-(2-((5-(4-chlorophenyl)-4-methyl-1H-pyrazol-3-yl)ox y)ethyl)-, monohydrochloride
CAS REGISTRY NUMBER :
86871-73-0
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C16-H20-Cl-N3-O2.Cl-H
MOLECULAR WEIGHT :
358.30

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
125 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0076756

Related Compounds

  • rac-[(1R,3R)-2,2-dimethyl-3-(2,2,2-trifluoroethyl)cyclopropyl]methanamine
  • rac-[(1R,2R)-2-(4-chloro-2-methylphenyl)cyclopropyl]methanamine
  • 5-{Bicyclo[2.2.1]heptan-2-yl}-1,2-oxazol-4-amine
  • [1-(2,3-Dichlorophenyl)-3,3-difluorocyclobutyl]methanamine
  • 3,3-Difluoro-1-(4-methylnaphthalen-1-yl)cyclobutan-1-amine
  • [3,3-Difluoro-1-(3-methyl-1,2-oxazol-5-yl)cyclobutyl]methanamine
  • 2-[3-Chloro-4-(trifluoromethoxy)phenyl]-1,1-difluoropropan-2-amine
  • (2R)-2-{2-[({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)methyl]butanamido}propanoic acid
  • 4-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanamido]pentanoic acid
  • (2S)-2-[3-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanamido]butanoic acid
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.